Viatris Inc.
VTRS
$11.57
$0.100.87%
Headlines
4/25/2024
-
Tickeron - Stocks
4/24/2024
-
SeekingAlpha
4/24/2024
-
Seeking Alpha - Long Ideas
4/24/2024
-
Zacks Investment Research
4/21/2024
-
Insider Monkey
4/20/2024
-
Tickeron - Stocks
4/19/2024
-
Zacks Investment Research
4/18/2024
-
The Online Investor
4/18/2024
-
The Online Investor
4/18/2024
-
Zacks Investment Research
4/18/2024
-
Insider Monkey
4/16/2024
-
PR Newswire
4/15/2024
-
BizJournals.com - Nat'l Business News
4/15/2024
-
FiercePharma
4/15/2024
-
The Fly
4/15/2024
-
PR Newswire
4/15/2024
-
Zacks Investment Research
4/15/2024
-
CNW Group - News Releases
4/12/2024
-
Dividend Channel
4/11/2024
-
The Online Investor
4/8/2024
-
SeekingAlpha
4/4/2024
-
Seeking Alpha - Healthcare
4/3/2024
-
GuruFocus
Teva, Viatris revive patent challenge on J&J's long-acting schizophrenia blockbuster Invega Sustenna
4/2/2024
-
FiercePharma
4/1/2024
-
Seeking Alpha - Healthcare
Filings
Wednesday, February 28, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
Corporate Info
724 514 1800
1000 Mylan Boulevard
Canonsburg, PA 15317
Canonsburg, PA 15317
Business Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs...
more